Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis

Published:2019-01-17 Issue:3 Volume:120 Page:301-305
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Eggemann Holm,Bernreiter Anna-Lena,Reinisch Mattea,Loibl Sibylle,Taran Florin-Andrei,Costa Serban-Dan,Ignatov Atanas

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0369-2.pdf

Reference20 articles.

1. Losurdo, A. et al. Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: a review of the literature. Crit. Rev. Oncol. Hematol. 113, 283–291 (2017).

2. Eggemann, H. et al. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast Cancer Res. Treat. 137, 465–470 (2013).

3. Eggemann, H., Altmann, U., Costa, S. D. & Ignatov, A. Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer. J. Cancer Res. Clin. Oncol. 144, 337–341 (2017).

4. Cuzick, J. et al. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360, 817–824 (2002).

5. Grady, D. et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann. Intern. Med. 132, 689–696 (2000).

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer;Breast Cancer;2024-06-15

2. Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship;Current Oncology Reports;2024-01

3. No evidence for a genetic causal effect of breast cancer on venous thromboembolism: a mendelian randomization study;Journal of Thrombosis and Thrombolysis;2023-08-24

4. High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer;World Journal of Clinical Cases;2023-07-16

5. The Risk of Venous Thromboembolism in Korean Patients with Breast Cancer: A Single-Center Experience;Cancers;2023-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3